S. Betuing

发表

A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington’s disease

Nicolas Heck, J. Caboche, P. Vanhoutte, 2011, Brain Structure and Function.

Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

C. Kahn, D. Severson, H. Taegtmeyer, 2002, The Journal of clinical investigation.

alpha2-Adrenoceptor stimulation promotes actin polymerization and focal adhesion in 3T3F442A and BFC-1beta preadipocytes.

P. Valet, M. Lafontan, J. Saulnier-Blache, 1996, Endocrinology.

Regulation of insulin-responsive aminopeptidase expression and targeting in the insulin-responsive vesicle compartment of glucose transporter isoform 4-deficient cardiomyocytes.

K. Kandror, E. Abel, P. Reay, 2004, Molecular endocrinology.

Functional consequences of constitutively active alpha2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes.

P. Valet, M. Lafontan, G. Hickson, 1997, Biochemical and biophysical research communications.

Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus.

J. Melki, C. Cifuentes-Díaz, V. Joshi, 2003, Human molecular genetics.

Identification of First-in-Class Inhibitors of Kallikrein-Related Peptidase 6 That Promote Oligodendrocyte Differentiation.

M. Louet, E. Duplus, Nancy Chaaya, 2021, Journal of medicinal chemistry.

MICROFLUIDIC CHIPS WITH "AXON DIODES" FOR DIRECTED AXONAL OUTGROWTH AND RE- CONSTRUCTION OF COMPLEX LIVE NEURAL NETWORKS

D. Kilinc, Sébastien Magnifico, B. Brugg, 2008 .

Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers.

Jean-Louis Viovy, Maéva Vignes, Paul Gougis, 2011, Lab on a chip.

Multiple Aspects of Gene Dysregulation in Huntington’s Disease

J. Caboche, S. Betuing, L. Moumné, 2013, Front. Neurol..

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

C. Pagès, J. Caboche, L. Galvan, 2016, Brain : a journal of neurology.

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter

C. Pagès, J. Caboche, N. Déglon, 2011, Human molecular genetics.

Chromatin Remodeling: Role in Neuropathologies of the Basal Ganglia

K. Brami-Cherrier, J. Caboche, E. Roze, 2010 .

Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse

Emmanuel Roze, Jean-Antoine Girault, J. Girault, 2009, Journal of neurochemistry.

Altered Cholesterol Homeostasis in Huntington’s Disease

J. Caboche, S. Betuing, C. Mounier, 2022, Frontiers in Aging Neuroscience.

Huntington's disease.

J. Caboche, C. Bonnet, E. Roze, 2010, Advances in experimental medicine and biology.

Gβγ-independent Coupling of α2-Adrenergic Receptor to p21 rhoA in Preadipocytes*

P. Valet, M. Lafontan, C. Pagès, 1998, The Journal of Biological Chemistry.

Huntington’s Disease and Striatal Signaling

J. Caboche, C. Bonnet, P. Vanhoutte, 2011, Front. Neuroanat..

Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo

C. Pagès, J. Caboche, N. Déglon, 2008, Neurobiology of Disease.

Cellular and Molecular Mechanisms of Neuronal Dysfunction in Huntington's Disease

J. Caboche, P. Vanhoutte, E. Roze, 2017 .

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease

Carlos A. Matos, J. Caboche, S. Carmo-Silva, 2020, BMC Research Notes.

Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin

J. Caboche, N. Déglon, E. Brouillet, 2017, The European journal of neuroscience.

Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation

J. Caboche, D. Charvin, E. Martin, 2009, PloS one.

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

C. Pagès, J. Caboche, L. Galvan, 2016, Brain : a journal of neurology.

CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.

J. Caboche, L. Venance, F. Saudou, 2019, Brain : a journal of neurology.

[Regulation of cholesterol metabolism is neuroprotective in Huntington's disease].

J. Caboche, S. Betuing, Radhia Kacher, 2020, Medecine sciences : M/S.

Rapid synaptogenesis in the Nucleus Accumbens is induced by a single cocaine administration and stabilized by MAP Kinase interacting kinase 1 activity

J. Caboche, M. Salery, B. Forget, 2017 .

Rapid synaptogenesis in the Nucleus Accumbens is induced by a single cocaine administration and stabilized by MAP Kinase interacting kinase 1 activity

M. Salery, Jocelyne, B. Forget, 2017 .

Disrupting D1-NMDA or D2-NMDA receptor heteromerization prevents cocaine’s rewarding effects but preserves natural reward processing

J. Caboche, J. Javitch, A. Bemelmans, 2021, Science advances.

Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum

J. Caboche, P. Vanhoutte, S. Betuing, 2023, International journal of molecular sciences.

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease

Carlos A. Matos, J. Caboche, S. Carmo-Silva, 2020, BMC Research Notes.

A deconvolution method to improve automated 3D-analysis of dendritic spines: application to a mouse model of Huntington’s disease

J. Caboche, P. Vanhoutte, N. Heck, 2012, Brain Structure and Function.

Disrupting D2-NMDA receptor heteromerization blocks the rewarding effects of cocaine but preserves natural reward processing

J. Caboche, J. Javitch, A. Bemelmans, 2021, bioRxiv.

Rapid Synaptogenesis in the Nucleus Accumbens Is Induced by a Single Cocaine Administration and Stabilized by Mitogen-Activated Protein Kinase Interacting Kinase-1 Activity

J. Caboche, M. Salery, B. Forget, 2017, Biological Psychiatry.

CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.

J. Caboche, M. Potier, P. Vanhoutte, 2018, Biochimie.

[Pathophysiology of Huntington's disease: an update].

M. Vidailhet, J. Caboche, E. Roze, 2008, Revue neurologique.

Regulation of insulin-responsive aminopeptidase expression and targeting in the insulin-responsive vesicle compartment of glucose transporter isoform 4-deficient cardiomyocytes.

K. Kandror, S. Betuing, T. Kupriyanova, 2004, Molecular endocrinology.

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter

C. Pagès, J. Caboche, N. Déglon, 2011, Human molecular genetics.